Dopamine agonists: their role in the treatment of Parkinson's disease.

@article{Brooks2000DopamineAT,
  title={Dopamine agonists: their role in the treatment of Parkinson's disease.},
  author={David J. Brooks},
  journal={Journal of neurology, neurosurgery, and psychiatry},
  year={2000},
  volume={68 6},
  pages={
          685-9
        }
}
Parkinson's disease is a chronic and disabling illness. There is still some uncertainty in its diagnosis, particularly in the early stages, as some other neurological conditions present with similar clinical features. There has been wide variation in the management of Parkinson's disease due to a lack of consensus on the best approach. Recently, United Kingdom specific guidelines for the management of Parkinson's disease have been produced1 which provide, where possible, evidence based… CONTINUE READING

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 54 CITATIONS, ESTIMATED 98% COVERAGE

L-dopa and the Serotonergic System

VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

A Probabilistic Analysis of Volume Transmission in the Brain

  • SIAM Journal of Applied Mathematics
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

FILTER CITATIONS BY YEAR

2001
2019

CITATION STATISTICS

  • 4 Highly Influenced Citations

  • Averaged 6 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 65 REFERENCES

Dyskinesias in Parkinson ’ s disease : A five year study of ropinirole versus lerodopa

O Rascol, DJ Brooks, AD Korezyn
  • New Eng J Med
  • 2000

Dyskinesias in Parkinson ’ s disease : A five year study of ropinirole versus lerodopa

O Rascol, DJ Brooks, AD Korezyn
  • New Eng J Med
  • 2000